SCHEMBL7010023

SCHEMBL7010023

O=C(O)CCS(=O)(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 2/20 0.68
MMP7 P09237 2/20 0.68
MMP14 P50281 2/20 0.68
HTT P42858 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
KDM4E B2RXH2 1/20 0.58
HDAC1 Q13547 1/20 0.56
HDAC2 Q92769 1/20 0.56
HSD11B1 P28845 1/20 0.56
MMP13 P45452 3/20 0.56
MMP1 P03956 2/20 0.56
MMP9 P14780 2/20 0.56
ALDH1A1 P00352 1/20 0.56
MMP3 P08254 1/20 0.56
MMP12 P39900 2/20 0.53
GAA P10253 1/20 0.53
MMP8 P22894 1/20 0.53
ADAMTS4 O75173 1/20 0.53
FFAR1 O14842 1/20 0.52
APEX1 P27695 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1001018 0.88 HSD11B1 (0.69) HTTNPSR1KDM4EHDAC1HDAC2
SCHEMBL7307785 0.88 MMP2 (0.54) MMP2MMP7MMP14HTTNPSR1
Hydrochloric Acid SCHEMBL10584023 0.86 HSD11B1 (0.67) HTTNPSR1KDM4EHDAC1HDAC2
SCHEMBL7010857 0.86 HSD11B1 (0.58) MMP2MMP7MMP14HTTNPSR1
SCHEMBL27466099 0.86 MMP2 (0.59) MMP2MMP7MMP14HDAC1HDAC2
SCHEMBL7014945 0.84 HTT (0.55) MMP2MMP7MMP14HTTNPSR1
SCHEMBL7077673 0.82 HTT (0.50) MMP2MMP7MMP14HTTNPSR1
SCHEMBL7075505 0.82 HSD11B1 (0.62) MMP2MMP7MMP14HTTNPSR1
SCHEMBL7862104 0.82 HDAC1 (0.57) MMP2MMP7MMP14HTTNPSR1
SCHEMBL7870815 0.81 HTT (0.64) HTTNPSR1KDM4EHSD11B1MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1168709-C Alpha-hydroxy, amino and -fluoro derivatives of beta-sulphenyl hydroxamic acids matrix metalloproteinases inhibitors ����Լ��ҩ�﹫˾ 2004-09-29 CN disclosed
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1302462-A1 SULFONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2003-04-16 EP disclosed
CN-1278247-A Alpha-hydroxy, -amino and halo derivatives of beta-sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors PHARMACIA & UPJHN CO (US) 2000-12-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof SULT1E1, RRS1, SHH MMP2 4420/4885MMP7 3988/4885MMP14 4447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.